Immune thrombocytopenia (ITP) trials in Sweden
2 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Huddinge, Malmo
- Age
- 18 years and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - Phase 3Taking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Huddinge, Malmo
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00